Skip to content

Development and Utilization of a Disease-Specific Biobank for a Systemic Sclerosis Cohort

Development and Utilization of a Disease-Specific Biobank for a Systemic Sclerosis Cohort

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500107696
Enrollment
Unknown
Registered
2025-08-18
Start date
2025-08-22
Completion date
Unknown
Last updated
2025-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic Sclerosis

Interventions

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients with scleroma need to meet the inclusion criteria of 123, and those with systemic sclerosis must meet the inclusion criteria of 124. 1. Age 18~60 years old, male or female. 2. Patients voluntarily participate in this study and sign the informed consent form. 3. The diagnostic criteria for spora are based on the diagnosis and classification criteria of spora at the 2004 Padua Consensus Conference in Italy. 4 Diagnostic criteria for systemic sclerosis are based on the 2013 American College of Rheumatology/European League Against Rheumatism Systemic Sclerosis criteria.

Exclusion criteria

Exclusion criteria: 1. Current symptoms and signs suggestive of an infection; 2. Patients with malignant tumors; 3. Patients known to have HIV, hepatitis B, hepatitis C, or other immune disorders

Design outcomes

Primary

MeasureTime frame
Skin sclerosis score;lung function;New or significantly worsening visceral involvement events;Deaths due to systemic sclerosis;

Countries

China

Contacts

Public ContactYang Ji

Zhongshan Hospital, Fudan University

yang.hua@yeah.net+86 158 2135 0315

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026